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Background
About 90% of mortality associated with cancer is attri-
butable to metastatic disease. Thus, our ability to treat
cancer is largely dependent on the capacity to prevent
metastasis. Metabolic reprogramming is recognized to
support cellular transformation and tumor initiation;
however, whether or how metabolism supports metastasis
remains an open question. This study seeks to identify
metabolic predictors of metastasis, with the rationale that
understanding metabolic changes will lead to novel
insights into metastasis and perhaps new therapies to treat
metastatic disease.
Materials and methods
A patient-derived xenograft model was used in which
metastasis in mice strongly correlates with metastatic
history of patient donors. Tumor cells were originally
obtained from melanoma patients and passaged exclu-
sively in highly immunocompromised mice [1]. In this
study, 17 of such tumor lines were investigated including
6 lines with low metastatic potential, 9 high metastatic
potential and 2 intermediate metastatic potential. Tumor
cells were implanted subcutaneously into mice, yielding
62 tumors. 3-4 biopsies from each primary tumor were
harvested, for a total of 185 samples. A mass spectrometry
(MS)-based analytical platform was used to characterize
>150 metabolites in each specimen. The relative
abundance of metabolites that contribute most to the
distinction of highly metastatic from inefficiently meta-
static melanomas was examined using statistical tools.
Results
Unsupervised hierarchical clustering revealed that in every
case, a given tumor biopsy was most closely related to all
other biopsies descended from the same parental tumor.
In addition, as a frequent mutation in melanoma, BRAF-
mutant tumors were easily distinguished from BRAF-wild
type tumors by their metabolomic signatures. More
importantly, several metabolic pathways were found
altered significantly when metabolomics profiles between
melanoma lines with high or low metastatic potentials
were compared.
Conclusions
The MS-based metabolomic analysis of patient-derived
melanoma xenografts demonstrates that tumors contain
individual metabolomic identities that can be tracked. It
may be possible to identify metabolomic features from
primary tumors that predict various aspects of tumor
biology, including the propensity to metastasize. The
altered metabolic pathways in highly metastatic melano-
mas are potential therapeutic targets.
Acknowledgements
The work was supported by a grant from the NIH (CA157996).
Authors’ details
1Children’s Medical Center Reserach Institute,UT Southwestern Medical
Center, Dallas, TX, USA. 2Howard Hughes Medical Institute, Chevy Chase, MD,
USA. 3McDermott Center for Human Growth and Development, University of
Texas Southwestern Medical Center, Dallas, TX, USA.
Published: 28 May 2014
Reference
1. Quintana E, Piskounova E, Shackleton M, Weinberg D, Eskiocak U, Fullen DR,
Johnson TM, Morrison SJ: Human melanoma metastasis in NSG mice
correlates with clinical outcome in patients. Sci Transl Med 2012,
4:159ra149.
doi:10.1186/2049-3002-2-S1-P67
Cite this article as: Shi et al.: Identifying metabolomic features that
predict metastasis of melanoma from a primary site. Cancer &
Metabolism 2014 2(Suppl 1):P67.
1Children’s Medical Center Reserach Institute,UT Southwestern Medical
Center, Dallas, TX, USA
Full list of author information is available at the end of the article
Shi et al. Cancer & Metabolism 2014, 2(Suppl 1):P67
http://www.cancerandmetabolism.com/content/2/S1/P67 Cancer & 
Metabolism
© 2014 Shi et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
